These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 24292392)

  • 1. Self-renewal as a therapeutic target in human colorectal cancer.
    Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
    Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer: targeting self-renewal of cancer stem cells in colorectal cancer-a future treatment option?
    Leake I
    Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):75. PubMed ID: 24345889
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer drugs: Curbing self-renewal of cancer-initiating cells.
    Crunkhorn S
    Nat Rev Drug Discov; 2014 Feb; 13(2):102. PubMed ID: 24481304
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting self-renewal, an Achilles' heel of cancer stem cells.
    Wicha MS
    Nat Med; 2014 Jan; 20(1):14-5. PubMed ID: 24398956
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
    Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X
    Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
    Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
    Nishida Y; Maeda A; Chachad D; Ishizawa J; Qiu YH; Kornblau SM; Kimura S; Andreeff M; Kojima K
    Cancer Sci; 2015 Dec; 106(12):1705-13. PubMed ID: 26450753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
    Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
    Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
    Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.
    Paquet-Fifield S; Koh SL; Cheng L; Beyit LM; Shembrey C; Mølck C; Behrenbruch C; Papin M; Gironella M; Guelfi S; Nasr R; Grillet F; Prudhomme M; Bourgaux JF; Castells A; Pascussi JM; Heriot AG; Puisieux A; Davis MJ; Pannequin J; Hill AF; Sloan EK; Hollande F
    Cancer Res; 2018 Jun; 78(11):2925-2938. PubMed ID: 29510994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
    Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
    Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.
    Zhang Y; Zhou SY; Yan HZ; Xu DD; Chen HX; Wang XY; Wang X; Liu YT; Zhang L; Wang S; Zhou PJ; Fu WY; Ruan BB; Ma DL; Wang Y; Liu QY; Ren Z; Liu Z; Zhang R; Wang YF
    Sci Rep; 2016 Feb; 6():19995. PubMed ID: 26847520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.